Dr. Titus Insights: Biotechs and Cannabis

by adminTorusBrand | Sep 16, 2016 | Axim Biotechnologies, Company News, Dr. Titus Insights, Kannalife Sciences, Scientific Research

This week: GW Pharma has numerous acquisition offers from bigger pharma Insys Therapeutics Spends $500,000 to defeat cannabis recreational legalization in home state, Arizona Canada to ask the US to re-think its ludicrous border policy re cannabis usage Technical 420...

Medical Marijuana, Inc. CEO Interviewed for Uptick Newswire; Discusses Latin Market Expansion, Portfolio Companies Kannaway and AXIM Biotech

by adminTorusBrand | Aug 4, 2016 | Axim Biotechnologies, Kannaway, Media Coverage, Press Releases

San Diego, CA – Aug. 4, 2016 – Medical Marijuana, Inc. (OTC: MJNA) announced today that the Company’s CEO Dr. Stuart Titus was interviewed by the Uptick Network’s Stock Day Radio Show about expanding access to cannabidiol (CBD)-based products to people across Latin...

Medical Marijuana, Inc. CEO to Speak August 7th at the Southern California Cannabis Conference and Expo

by adminTorusBrand | Aug 2, 2016 | Axim Biotechnologies, Company News, Kannalife Sciences

Dr. Stuart Titus, President and CEO of Medical Marijuana, Inc., will give a talk covering the potential market for CBD in the U.S. and worldwide. The cannabis industry will descend on Medical Marijuana, Inc.’s hometown the weekend of August 6-7th when the Southern...

AXIM Biotechnologies Begins Clinical Studies for Cannabigerol (CBG) Based Topical Ointment for Skin Diseases

by adminTorusBrand | May 18, 2016 | Axim Biotechnologies, Company News

AXIM Biotechnologies announced that they are conducting proof of concept clinical trials for their CBG-based ointment for the treatment of psoriasis and eczema. AXIM Biotechnologies, a significant investment company for Medical Marijuana, Inc., has begun the first...

Medical Marijuana, Inc.’s Investment, AXIM Biotech, Launches World’s First Cannabigerol (CBG) Clinical Trials on Psoriasis and Eczema

by adminTorusBrand | May 17, 2016 | Axim Biotechnologies, Company News, Press Releases

MJNA’s Cannabis-Based Drug Development R&D Plans Expand With AXIM Biotech’s Clinical Trials On Patent-Pending AX-1602 Including Cannabigerol (CBG) SAN DIEGO, CA – May 17, 2016 — Medical Marijuana, Inc. (OTC: MJNA) is pleased to announce that its hemp biotech...

4/20 a Big Day for U.S. Marijuana Sales, Media Coverage for Medical Marijuana, Inc.

by adminTorusBrand | May 7, 2016 | Axim Biotechnologies, Cannabis Beauty Defined, Industry Updates, Kannactiv, Media Coverage

This year’s unofficial cannabis holiday brought in nearly $38 million in marijuana sales in the United States, as well as a series of press articles highlighting Medical Marijuana Inc.’s leading position in the country’s booming industry. Retail marijuana...